JP2023518439A5 - - Google Patents
Info
- Publication number
- JP2023518439A5 JP2023518439A5 JP2022556142A JP2022556142A JP2023518439A5 JP 2023518439 A5 JP2023518439 A5 JP 2023518439A5 JP 2022556142 A JP2022556142 A JP 2022556142A JP 2022556142 A JP2022556142 A JP 2022556142A JP 2023518439 A5 JP2023518439 A5 JP 2023518439A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotides
- dsrna
- antisense
- chain
- antisense strand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026025899A JP2026106461A (ja) | 2020-03-18 | 2026-02-20 | Mapt調節のためのオリゴヌクレオチド |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062991405P | 2020-03-18 | 2020-03-18 | |
| US62/991,405 | 2020-03-18 | ||
| US202063071106P | 2020-08-27 | 2020-08-27 | |
| US63/071,106 | 2020-08-27 | ||
| PCT/US2021/022688 WO2021188626A1 (en) | 2020-03-18 | 2021-03-17 | Oligonucleotides for mapt modulation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026025899A Division JP2026106461A (ja) | 2020-03-18 | 2026-02-20 | Mapt調節のためのオリゴヌクレオチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518439A JP2023518439A (ja) | 2023-05-01 |
| JP2023518439A5 true JP2023518439A5 (cg-RX-API-DMAC7.html) | 2024-03-28 |
Family
ID=77768304
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556142A Pending JP2023518439A (ja) | 2020-03-18 | 2021-03-17 | Mapt調節のためのオリゴヌクレオチド |
| JP2026025899A Pending JP2026106461A (ja) | 2020-03-18 | 2026-02-20 | Mapt調節のためのオリゴヌクレオチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026025899A Pending JP2026106461A (ja) | 2020-03-18 | 2026-02-20 | Mapt調節のためのオリゴヌクレオチド |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20210363523A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4121537A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023518439A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230004448A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115552006A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021238319A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3171246A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022011516A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021188626A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3929293A3 (en) | 2015-04-03 | 2022-03-16 | University Of Massachusetts | Fully stabilized asymmetric sirna |
| WO2017030973A1 (en) | 2015-08-14 | 2017-02-23 | University Of Massachusetts | Bioactive conjugates for oligonucleotide delivery |
| WO2018237245A1 (en) | 2017-06-23 | 2018-12-27 | University Of Massachusetts | TWO TAIL SELF-ADMINISTRATION SIRNA AND ASSOCIATED METHODS |
| BR112021002440A2 (pt) | 2018-08-10 | 2021-05-04 | University Of Massachusetts | oligonucleotídeos modificados visando snps |
| WO2020041769A1 (en) | 2018-08-23 | 2020-02-27 | University Of Massachusetts | O-methyl rich fully stabilized oligonucleotides |
| CN113614232A (zh) | 2019-01-18 | 2021-11-05 | 马萨诸塞大学 | 动态药代动力学修饰锚 |
| KR20220047989A (ko) | 2019-08-09 | 2022-04-19 | 유니버시티 오브 매사추세츠 | Snp를 표적화하는 화학적으로 변형된 올리고뉴클레오타이드 |
| US12365894B2 (en) | 2019-09-16 | 2025-07-22 | University Of Massachusetts | Branched lipid conjugates of siRNA for specific tissue delivery |
| JP2023521604A (ja) * | 2020-03-30 | 2023-05-25 | アルナイラム ファーマシューティカルズ, インコーポレイテッド | 微小管関連タンパク質タウ(MAPT)iRNA剤組成物およびその使用方法 |
| CA3174079A1 (en) | 2020-05-26 | 2021-12-02 | Anastasia Khvorova | Synthetic oligonucleotides having regions of block and cluster modifications |
| KR20240067943A (ko) * | 2021-09-24 | 2024-05-17 | 알닐람 파마슈티칼스 인코포레이티드 | 미소관 연관 단백질 타우(MAPT) iRNA 제제 조성물 및 이의 사용 방법 |
| US20250340872A1 (en) * | 2021-10-07 | 2025-11-06 | Ionis Pharmaceuticals, Inc. | Compounds and methods for reducing tau expression |
| MX2024007056A (es) * | 2021-12-13 | 2024-06-24 | Lilly Co Eli | Agentes de interferencia de arn de mapt. |
| US20250171777A1 (en) * | 2022-02-11 | 2025-05-29 | Alnylam Pharmaceuticals, Inc. | Microtubule Associated Protein Tau (MAPT) iRNA Agent Compositions and Methods of Use Thereof |
| US20230392146A1 (en) * | 2022-03-11 | 2023-12-07 | University Of Massachusetts | Oligonucleotides for app modulation |
| WO2023193004A2 (en) * | 2022-04-01 | 2023-10-05 | Triplet Therapeutics, Inc. | Methods for the treatment of neurodegenerative disorders |
| CA3247389A1 (en) * | 2022-05-12 | 2023-11-16 | Dicerna Pharmaceuticals, Inc. | COMPOSITIONS AND METHODS FOR INHIBITING THE EXPRESSION OF MAPT |
| CA3246379A1 (en) * | 2022-05-13 | 2023-11-16 | Julius-Maximilians-Universität Würzburg | METHOD AND MOLECULES FOR REDUCING AXONAL TAU PROTEIN ACCUMULATION BY BLOCKING HNRNP R-MEDICATED MRNA TRANSPORT FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
| WO2024073618A2 (en) * | 2022-09-29 | 2024-04-04 | Atalanta Therapeutics, Inc. | Sirna compositions and methods targeting microtubule associated protein tau nucleic acids |
| WO2024145474A2 (en) * | 2022-12-29 | 2024-07-04 | Voyager Therapeutics, Inc. | Compositions and methods for regulating mapt |
| WO2024201423A2 (en) * | 2023-03-30 | 2024-10-03 | Biorchestra Co., Ltd. | Microtubule-associated protein tau targeting sirnas and uses thereof |
| EP4698652A2 (en) * | 2023-04-20 | 2026-02-25 | Adarx Pharmaceuticals, Inc. | Mapt-modulating compositions and methods of use thereof |
| KR20260046111A (ko) * | 2023-08-01 | 2026-04-06 | 투오지에 바이오텍 (상하이) 컴퍼니 리미티드 | MAPT를 표적으로 하는 dsRNA 및 이의 의약적 용도 |
| KR20260085142A (ko) * | 2023-10-11 | 2026-06-08 | 상하이 아르고 바이오파마슈티칼 씨오., 엘티디. | 미세소관 관련 단백질 tau(mapt)의 발현을 억제하기 위한 조성물 및 방법 |
| WO2025212467A1 (en) * | 2024-03-31 | 2025-10-09 | Arrowhead Pharmaceuticals, Inc. | Rnai agents for inhibiting expression of microtubule associated protein tau (mapt), compositions thereof, and methods of use |
| WO2025233849A2 (en) * | 2024-05-07 | 2025-11-13 | Janssen Pharmaceutica Nv | MAPT siRNA AND USES THEREOF |
| US20260167963A1 (en) * | 2024-08-29 | 2026-06-18 | Synerk Inc. | Compounds, Compositions and Methods for Reducing MAPT (TAU) Expression |
| WO2026090357A1 (en) * | 2024-10-24 | 2026-04-30 | Adarx Pharmaceuticals, Inc. | Mapt-modulating oligonucleotides for treating central nervous system diseases |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050255086A1 (en) * | 2002-08-05 | 2005-11-17 | Davidson Beverly L | Nucleic acid silencing of Huntington's Disease gene |
| CA2585970A1 (en) * | 2004-10-27 | 2006-05-04 | Vanderbilt University | Mammalian genes involved in infection |
| GB0605337D0 (en) * | 2006-03-17 | 2006-04-26 | Genomica Sau | Treatment of CNS conditions |
| WO2008124066A1 (en) * | 2007-04-05 | 2008-10-16 | The J. David Gladstone Institutes | Agents that reduce neuronal overexcitation |
| WO2010141511A2 (en) * | 2009-06-01 | 2010-12-09 | Halo-Bio Rnai Therapeutics, Inc. | Polynucleotides for multivalent rna interference, compositions and methods of use thereof |
| TWI702046B (zh) * | 2013-07-19 | 2020-08-21 | 美商Ionis製藥公司 | 用於調節τ蛋白表現之組合物 |
| ES2820713T3 (es) * | 2015-03-25 | 2021-04-22 | Univ Degli Studi Di Trento | Terapia mediada por ARN interferente para enfermedades neurodegenerativas |
| EP3929293A3 (en) * | 2015-04-03 | 2022-03-16 | University Of Massachusetts | Fully stabilized asymmetric sirna |
| WO2017132669A1 (en) * | 2016-01-31 | 2017-08-03 | University Of Massachusetts | Branched oligonucleotides |
| WO2020041769A1 (en) * | 2018-08-23 | 2020-02-27 | University Of Massachusetts | O-methyl rich fully stabilized oligonucleotides |
| US20210115442A1 (en) * | 2019-08-23 | 2021-04-22 | University Of Massachusetts | O-methyl rich fully stabilized oligonucleotides |
-
2021
- 2021-03-17 JP JP2022556142A patent/JP2023518439A/ja active Pending
- 2021-03-17 MX MX2022011516A patent/MX2022011516A/es unknown
- 2021-03-17 KR KR1020227031792A patent/KR20230004448A/ko active Pending
- 2021-03-17 AU AU2021238319A patent/AU2021238319A1/en active Pending
- 2021-03-17 CN CN202180034587.6A patent/CN115552006A/zh active Pending
- 2021-03-17 WO PCT/US2021/022688 patent/WO2021188626A1/en not_active Ceased
- 2021-03-17 US US17/204,480 patent/US20210363523A1/en not_active Abandoned
- 2021-03-17 EP EP21770963.3A patent/EP4121537A4/en active Pending
- 2021-03-17 CA CA3171246A patent/CA3171246A1/en active Pending
-
2025
- 2025-09-24 US US19/338,285 patent/US20260109982A1/en active Pending
-
2026
- 2026-02-20 JP JP2026025899A patent/JP2026106461A/ja active Pending